{"id":164,"date":"2010-12-08T19:44:24","date_gmt":"2010-12-08T19:44:24","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=164"},"modified":"2010-12-08T19:44:24","modified_gmt":"2010-12-08T19:44:24","slug":"gsk-to-buy-nanjing-meirui-pharma","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2010\/12\/08\/gsk-to-buy-nanjing-meirui-pharma\/","title":{"rendered":"GSK Buys Nanjing Meirui Pharma"},"content":{"rendered":"<p><span style=\"color: #333399\"><em><strong>2010-12-08<\/strong><\/em><\/span><\/p>\n<p><strong>The British pharmaceutical company GSK (GlaxoSmithKline) has officially confirmed that they&#8217;re planning to take over Nanjing MeiRui Pharma Co., Inc for a price of 70 million USD, and this acquisition is expected to be completed before the New Year.<\/strong><\/p>\n<h3>\u845b\u5170\u7d20\u53f2\u514b\u786e\u8ba4\u6536\u8d2d\u5357\u4eac\u7f8e\u745e\u5236\u836f<\/h3>\n<p>2010\u5e7412\u670807\u65e5 19:51 \u65b0\u6d6a\u8d22\u7ecf<\/p>\n<p>\u65b0\u6d6a\u8d22\u7ecf\u8baf 12\u67087\u65e5\u665a\u95f4\u6d88\u606f\uff0c\u636e\u5916\u7535\u62a5\u9053\uff0c\u845b\u5170\u7d20\u53f2\u514b\u4eca\u65e5\u516c\u5e03\uff0c\u5c06\u65a5\u8d447,000\u4e07\u7f8e\u5143\u6536\u8d2d\u5357\u4eac\u7f8e\u745e\u5236\u836f\uff0c\u4ea4\u6613\u4ecd\u6709\u5f85\u76d1\u7ba1\u673a\u6784\u7684\u6279\u51c6\uff0c\u9884\u8ba1\u5c06\u4e8e2010\u5e74\u5e74\u5e95\u524d\u5b8c\u6210\u3002<\/p>\n<p>\u636e\u8def\u900f\u793e\u62a5\u9053\uff0c\u5236\u836f\u5de8\u5934\u845b\u5170\u7d20\u53f2\u514b7\u65e5\u516c\u5e03\uff0c\u5df2\u5c31\u65a5\u8d447,000\u4e07\u7f8e\u5143\u6536\u8d2d\u5357\u4eac\u7f8e\u745e\u5236\u836f\u6709\u9650\u516c\u53f8\u8fbe\u6210\u534f\u8bae\u3002<\/p>\n<p>\u845b\u5170\u7d20\u53f2\u514b\u5c06\u4ecePagoda Pharmaceuticals Limited\u624b\u4e2d\u6536\u8d2d\u5357\u4eac\u7f8e\u745e\u5236\u836f90%\u7684\u80a1\u4efd\uff0c\u5269\u4f5910%\u7684\u80a1\u4efd\u5c06\u4eceAllergon AB\u624b\u4e2d\u6536\u8d2d\uff0c\u6b64\u4e3e\u5c06\u8fdb\u4e00\u6b65\u6269\u5927\u845b\u5170\u7d20\u53f2\u514b\u5728\u4e2d\u56fd\u7684\u4e1a\u52a1\u8303\u56f4\u3002<\/p>\n<p>\u4e0a\u8ff0\u4ea4\u6613\u4ecd\u6709\u5f85\u76d1\u7ba1\u673a\u6784\u7684\u6279\u51c6\uff0c\u9884\u8ba1\u5c06\u4e8e2010\u5e74\u5e74\u5e95\u524d\u5b8c\u6210\u3002<\/p>\n<p>\u4e2d\u6295\u987e\u95ee\u533b\u836f\u884c\u4e1a\u7814\u7a76\u5458\u90ed\u51e1\u793c\u6307\u51fa\uff0c\u845b\u5170\u7d20\u53f2\u514b\u9047\u5230\u5f88\u591a\u8de8\u56fd\u533b\u836f\u4f01\u4e1a\u906d\u9047\u7684\u95ee\u9898\uff0c\u90a3\u5c31\u662f\u4e13\u5229\u5373\u5c06\u5230\u671f\u548c\u539f\u7814\u836f\u88ab\u53d6\u6d88\u7684\u53ef\u80fd\u3002\u5728\u8fd9\u79cd\u60c5\u51b5\u4e0b\uff0c\u845b\u5170 \u7d20\u53f2\u514b\u66f4\u503e\u5411\u4e8e\u6253\u5f00\u65b0\u5174\u5e02\u573a\uff0c\u5982\u5370\u5ea6\u548c\u4e2d\u56fd\u3002\u6b64\u6b21\u6536\u8d2d\u5c06\u5f25\u8865\u5176\u4e13\u5229\u836f\u5230\u671f\u540e\u5229\u6da6\u4e0b\u6ed1\u7684\u5f71\u54cd\u3002\u53e6\u5916\uff0c\u845b\u5170\u7d20\u53f2\u514b\u770b\u4e2d\u5357\u4eac\u7f8e\u745e\u5236\u836f\u7684\u9500\u552e\u6e20\u9053\u548c\u533b\u7597\u8d44\u6e90\u3002<\/p>\n<p>\u5357\u4eac\u7f8e\u745e\u6210\u7acb\u4e8e1996\u5e74\uff0c\u662f\u4e00\u5bb6\u4e13\u4e1a\u4ece\u4e8b\u6ccc\u5c3f\u7cfb\u7edf\u75be\u75c5\u8bca\u65ad\u548c\u6cbb\u7597\u7684\u76f8\u5173\u836f\u54c1\u4f01\u4e1a\u3002\u7531\u7f8e\u56fd\u8fdc\u4e1c\u8377\u514b\u96c6\u56e2\u516c\u53f8\u3001\u5357\u4eac\u533b\u836f(13.04,0.11,0.85%)\u80a1\u4efd\u6709\u9650\u516c\u53f8\u4ee5\u53ca\u745e\u5178\u6cd5\u739b\u897f\u4e9a\u516c\u53f8\u5408\u8d44\u6210\u7acb\uff0c\u5176\u4e2d\u7f8e\u65b9\u5360\u670950%\u80a1\u6743\uff0c\u5357\u4eac\u533b\u836f\u80a1\u4efd\u516c\u53f8\u5360\u670940%\u80a1\u6743\u30022008\u5e74\uff0c\u5357\u4eac\u533b\u836f\u51fa\u8ba9\u4e86\u8fd9\u90e8\u5206\u80a1\u6743\uff0c\u7531\u5916\u65b9\u80a1\u4e1c\u63a5\u624b\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2010-12-08 The British pharmaceutical company GSK (GlaxoSmithKline) has officially confirmed that they&#8217;re planning to take over Nanjing MeiRui Pharma Co., Inc for a price of 70 million USD, and this [&hellip;]<\/p>\n","protected":false},"author":951,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[5],"tags":[7],"class_list":["post-164","post","type-post","status-publish","format-standard","hentry","category-pharmaceutical-company-news","tag-consolidation"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/951"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=164"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/164\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}